Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs115591316 | chr7:157942186 | A/C | 0 | 481 | 31.27 | 30.8 | 12.87 | KM Plot |
PRAD | rs11570067 | chr11:47366095 | G/T | 2.2E-6 | 476 | 30.8 | 31.4 | 20.93 | KM Plot |
PRAD | rs11571313 | chr2:204821605 | C/T | 3.01E-5 | 492 | 30.8 | 31.87 | 20.33 | KM Plot |
PRAD | rs11583890 | chr1:6693876 | A/G | 0.000166 | 473 | 29.97 | 31.27 | 30.73 | KM Plot |
PRAD | rs115865323 | chr5:154135802 | C/T | 0 | 490 | 30.08 | 33.47 | 4.87 | KM Plot |
PRAD | rs11595321 | chr10:99402681 | C/T | 3.59E-6 | 482 | 31.27 | 29.12 | 24.67 | KM Plot |
PRAD | rs115956035 | chr4:187812329 | G/A | 2.09E-6 | 482 | 31.07 | 28.93 | 26.8 | KM Plot |
PRAD | rs11602024 | chr11:36310244 | G/C | 8.73E-5 | 484 | 31.07 | 32.47 | 26.37 | KM Plot |
PRAD | rs11602270 | chr11:93584622 | G/A | 3.64E-5 | 477 | 32.32 | 28.22 | 29.63 | KM Plot |
PRAD | rs11602366 | chr11:72456501 | G/A | 7.48E-5 | 479 | 30.53 | 33.47 | 22.37 | KM Plot |
PRAD | rs116030684 | chr11:129943288 | T/A | 1.17E-5 | 492 | 30.87 | 33.13 | 22.67 | KM Plot |
PRAD | rs116081712 | chr20:61662588 | A/G | 8.11E-6 | 484 | 31.07 | 30.27 | 24.15 | KM Plot |
PRAD | rs116081973 | chr5:154131460 | T/A | 0 | 490 | 30.08 | 33.47 | 4.87 | KM Plot |
PRAD | rs11609955 | chr12:771677 | C/G | 0.000133 | 494 | 30.27 | 32.63 | 29.17 | KM Plot |
PRAD | rs116107867 | chr5:154132098 | C/T | 0 | 490 | 30.08 | 33.47 | 4.87 | KM Plot |